RecruitingPhase 3NCT06492616
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Sponsor: Stemline Therapeutics, Inc.
Boston, MA · +173 more sites
4 recruiting breast cancer studies with a site in Methuen, MA.
Sponsor: Stemline Therapeutics, Inc.
Boston, MA · +173 more sites
Sponsor: NRG Oncology
Beverly, MA · Boston, MA · +1223 more sites
Sponsor: Alliance for Clinical Trials in Oncology
Boston, MA · +825 more sites
Sponsor: Guerbet
Boston, MA · +13 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.